Financial Advisor and Capital Markets Advisor. The biotech firm said it expects the deal to close in the third quarter of this year, after which it plans to list on the Nasdaq under the ticker symbol “ROIV.” (Reporting by Niket Nishant and Dania Nadeem in Bengaluru Editing by Ramakrishnan M. Business Combination with Montes Archimedes Acquisition Corp.
In February, the company said it would buy drug developer Silicon Therapeutics for $450 million to strengthen its artificial intelligence capabilities for drug discovery.įollowing its acquisition, Roivant will continue to be led by Chief Executive Officer Matthew Gline, while founder Vivek Ramaswamy will remain executive chairman. Price-Forecasting Models for Montes Archimedes Acquisition Corp MAACU Stock (Bernard Arnault) Ta, Ton Viet on. Montes Archimedes Acquisition Corp is primarely in the business of blank checks. SPACs are shell companies that raise funds through an IPO to take a private company public through a merger at a later date.įounded in 2014, Roivant has multiple subsidiaries focused on developing treatments for multiple cancers, nervous system and immune system disorders, including Immovovant Inc and Sio Gene Therapies Inc. Montes Archimedes Acquisition Corp is incorporated in the state of Delaware. Montes Archimedes went public in a $400 million initial public offering (IPO) in October last year and is sponsored by Patient Square Capital Patient, which was launched by Momtazee to pursue private equity deals in the healthcare sector. Shares of Montes Archimedes Acquisition were up 3.5% at $10.2 before the bell. It is formed for the business purpose to effect a merger, capital stock exchange, asset. The next issue of Financial Post Top Stories will soon be in your inbox. Montes Archimedes Acquisition Corp operates as a blank check company. If you don't see it, please check your junk folder. focuses to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business. Our management team has extensive experience in identifying and executing strategic investments predominantly focused on European medium-sized companies and has done so successfully in a number of sectors, including Industrial Manufacturing, Healthcare & Services, Consumer and Technology.A welcome email is on its way. Roivant will get 611 million in cash by merging with Montes Archimedes Acquisition Corp., a special purpose acquisition company, or SPAC, formed by. While we may pursue an initial business combination opportunity in any industry or sector, we intend to capitalize on the ability of our management team to identify, acquire and manage a business or businesses that can benefit from our management team’s established global relationships and operating experience. Roivant Sciences, an unusual holding company with roughly a dozen biotech subsidiaries, will go public through a merger with a blank-check entity in a deal that values the company at 7.3 billion. Our efforts to identify a potential initial business combination target will not be limited to a specific industry, sector or geographic region. Upon closing of the transaction, outstanding shares and warrants of MAAC will be exchanged for newly issued shares. (Nasdaq: MAAC), today announced that they have entered into a definitive business combination agreement. THIS WARRANT AGREEMENT (this Agreement), dated as of, 2020. In depth view into Montes Archimedes Acquisition Net Income From. CONTINENTAL STOCK TRANSFER & TRUST COMPANY. We have not identified any potential business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any potential business combination target. Roivant Sciences, a biopharmaceutical and healthcare technology company, and Montes Archimedes Acquisition Corp. With a market capitalization of US500m, Montes Archimedes Acquisition is a small cap stock, so it might not be well known by many institutional investors. MAAC Net Income From Continuing Operations as of today (August 20, 2022) is 0.00 Mil. We are a newly incorporated blank check company incorporated as a Cayman Islands exempted company and incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination.
0 kommentar(er)
